Enable new Parkinson treatment development
- Trial ID
- NCT06203106
- Official Title
- NYSCF Scientific Discovery Biobank
- Goal
- Enable new Parkinson treatment development
- Status
- RECRUITING
- Sponsor
- New York Stem Cell Foundation Research Institute
- Study Type
- OBSERVATIONAL
- Enrollment
- 10000 participants
- Conditions
- ALS, Amyotrophic Lateral Sclerosis, Alzheimer Disease, Alzheimer Disease, Early Onset, Alzheimer Disease, Late Onset, Batten Disease, Corticobasal Degeneration, Dementia, Frontotemporal Dementia, Huntington Disease, Lewy Body Disease, Multiple Sclerosis, Multiple System Atrophy, Parkinson Disease, Parkinson's Disease and Parkinsonism, Progressive Supranuclear Palsy, INAD, Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Macular Degeneration, Ovarian Cancer, Cervical Cancer, Uterine Cancer, Vaginal Cancer, Vulvar Cancer, PTSD, Post Traumatic Stress Disorder
- Interventions
- Biological Sample Collection
Summary For Families
The goal is to build a large, shared biobank of blood, saliva, skin, and transferred samples linked to medical data so researchers can speed up discovery of biomarkers and new treatments for Parkinson's and many other neurological and medical conditions. Participants provide samples that can be used to extract DNA, measure proteins, create induced pluripotent stem cell lines, and run lab studies to understand disease mechanisms or test experimental therapies. The study is open to people 30 days and older who have Parkinson's disease or other listed conditions, or who are healthy controls, with adults providing consent and people without decisional capacity allowed with assent plus a legally authorized representative consent. People who are wards of the state, who have certain bleeding or skin-healing problems relevant to sample collection, or who have AIDS with CD4 under 200 are excluded.
Locations
- New York Stem Cell Foundation Research Institute, New York, New York, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Biological Sample Collection. The goal is to build a large, shared biobank of blood, saliva, skin, and transferred samples linked to medical data so researchers can speed up discovery of biomarkers and new treatments for Parkinson's and many other neurological and medical conditions. Participants provide samples that can be used to extract DNA, measure proteins, create induced pluripotent stem cell lines, and run lab studies to understand disease mechanisms or test experimental therapies. The study is open to people 30 days and older who have Parkinson's disease or other listed conditions, or who are healthy controls, with adults providing consent and people without decisional capacity allowed with assent plus a legally authorized representative consent. People who are wards of the state, who have certain bleeding or skin-healing problems relevant to sample collection, or who have AIDS with CD4 under 200 are excluded.
- Who can participate?
- Participants must be at least 30 Days.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 23 years.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.